Search - tctmd.com

Displaying 581 - 600 of 2033

Sort: Relevancy | Date

Long-term Watchman Data Reassure: CAP and CAP2 Registries

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

News Conference News AHA 2019

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

November 22, 2019

Two Small Series Support Role for Cerebral Protection in TAVR

News Conference News PCR London Valves 2019

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

November 17, 2019

Inclisiran Slashes LDL in ASCVD Patients: ORION-10

News Conference News AHA 2019

Inclisiran Slashes LDL in ASCVD Patients: ORION-10

Yael L. Maxwell

November 16, 2019

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

Future Pulmonary Embolism Interventions: Wild West or Working Together?

News Conference News VIVA 2019

Future Pulmonary Embolism Interventions: Wild West or Working Together?

November 14, 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

November 06, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

Sapien 3 Valve Approved in Europe for Low-Risk Patients

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

AMBULATE: Venous Closure Device Pays Off After Catheter Ablation

News Daily News

AMBULATE: Venous Closure Device Pays Off After Catheter Ablation

October 31, 2019

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

October 21, 2019

FDA Gives Rivaroxaban Another VTE-Related Indication

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

October 14, 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

October 10, 2019

Interventional Options and Future Directions for Acute PE: New AHA Statement

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

October 07, 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

October 04, 2019

The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval

Presentation TCT 2019

The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval

Presenter: Andrew Farb

September 28, 2019

After the Champagne for PMA Approval Come Your Obligations: Inspections, Postapproval Studies, Medical Device Reporting, and Recalls

Presentation TCT 2019

After the Champagne for PMA Approval Come Your Obligations: Inspections, Postapproval Studies, Medical Device Reporting, and Recalls

Presenter: Megha Reddy

September 28, 2019

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

Presentation TCT 2019

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

Presenter: Vinod Thourani

September 27, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.